ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹556 Cr | ₹282 Cr | ₹358 Cr | ₹621 Cr |
What is the latest Total Non-Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹556 Cr |
| Mar2024 | ₹282 Cr |
| Mar2023 | ₹358 Cr |
| Mar2022 | ₹621 Cr |
How is Total Non-Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹556 Cr | 96.98 | |
| Mar2024 | ₹282 Cr | -21.17 | |
| Mar2023 | ₹358 Cr | -42.35 | |
| Mar2022 | ₹621 Cr | - | |
Compare Total Non-Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹19,441.1 Cr | -1.3% | 2% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -1.3% |
2% |
-17.2% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses